Literature DB >> 2724415

Genetic and biochemical characterization of the thymidine kinase gene from herpesvirus of turkeys.

S L Martin1, D I Aparisio, P K Bandyopadhyay.   

Abstract

The thymidine kinase gene encoded by herpesvirus of turkeys has been identified and characterized. A viral mutant (ATR0) resistant to 1-beta-D-arabinofuranosylthymine was isolated. This mutant was also resistant to 1-(2-fluoro-2-deoxy-beta-D-arabinofuronosyl)-5-methyluracil and was unable to incorporate [125I]deoxycytidine into DNA. The mutant phenotype was rescued by a cloned region of the turkey herpesvirus genome whose DNA sequence was found to contain an open reading frame similar to that for known thymidine kinases from other viruses. When expressed in Escherichia coli, this open reading frame complemented a thymidine kinase-deficient strain and resulted in thymidine kinase activity in extracts assayed in vitro.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2724415      PMCID: PMC250796     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Possible peptide chain termination mutants in thymide kinase gene of a mammalian virus, herpes simplex virus.

Authors:  W P Summers; M Wagner; W C Summers
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

2.  A conserved open reading frame that overlaps the herpes simplex virus thymidine kinase gene is important for viral growth in cell culture.

Authors:  J G Jacobson; S L Martin; D M Coen
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

3.  Phosphorylation of 5-bromodeoxycytidine in cells infected with herpes simplex virus.

Authors:  G M Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

4.  Induction of both thymidine and deoxycytidine kinase activity by herpes viruses.

Authors:  A T Jamieson; G A Gentry; J H Subak-Sharpe
Journal:  J Gen Virol       Date:  1974-09       Impact factor: 3.891

5.  Responses of cell cultures from various avian species to Marek's disease virus and herpesvirus of turkeys.

Authors:  H G Purchase; B R Burmester; C H Cunningham
Journal:  Am J Vet Res       Date:  1971-11       Impact factor: 1.156

6.  A deoxythymidine kinase deficient mutant of Escherichia coli. II. Mapping and transduction studies with phage phi 80.

Authors:  K Igarashi; S Hiraga; T Yura
Journal:  Genetics       Date:  1967-11       Impact factor: 4.562

7.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

8.  In vitro methods for assay of turkey herpesvirus.

Authors: 
Journal:  Avian Dis       Date:  1972-04       Impact factor: 1.577

9.  Susceptibility of mammalian and avian cell cultures to infection with cell-free turkey herpes virus.

Authors:  G Meulemans; P Halen; P Schyns; H Vindevogel
Journal:  J Comp Pathol       Date:  1973-10       Impact factor: 1.311

10.  [125I]deoxycytidine used in a rapid, sensitive, and specific assay for herpes simplex virus type 1 thymidine kinase.

Authors:  W C Summers; W P Summers
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

View more
  4 in total

1.  The genome of turkey herpesvirus.

Authors:  C L Afonso; E R Tulman; Z Lu; L Zsak; D L Rock; G F Kutish
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Construction of a pigeonpox virus recombinant: expression of the Newcastle disease virus (NDV) fusion glycoprotein and protection of chickens against NDV challenge.

Authors:  C Letellier; A Burny; G Meulemans
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

3.  Cosmid cloning and restriction endonuclease mapping of the herpesvirus of turkeys (HVT) genome.

Authors:  W Lindenmaier; H J Bauer
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

4.  Role of the TK+ phenotype in the stability of pigeonpox virus recombinant.

Authors:  C Letellier
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.